If this is your company, CONTACT US to activate Packbase™ software to build your portal.
What are the key trends and topics that will be relevant for 2016 and beyond? What are the challenges facing the industry and who are the Thought Leaders that can deliver real, innovative solutions? Be part of the conversation and help to shape the 2016 event.
By sharing your opinion in our Content Survey – which should take no more than 5 minutes to complete – you are also in with the chance to win a free seat to the Pre-Connect Congress for you or a colleague. Click the link below and submit your answers by Friday 8th April to be in with a chance.
https://www.surveymonkey.co.uk/r/WYNGFWH
Thank you for your insight!
Tara Dougal
Senior Content Producer
CPhI Pharmaceutical Portfolio
UBM EMEA
Whether you're interested in pharmaceutical ingredients, contract manufacturing, machinery or packaging solutions, CPhI Istanbul will gather the supplier contacts, ideas for product innovation and the insight you need to succeed in this region.
Join CPhI Istanbul TODAY and benefit from:
We've put together our best ever show, which gathers the leading suppliers in the region, expert speakers from the region's top brands and institutions and a one of a kind Matchmaking Programme for you to build new partnerships.
- FREE CPhI Istanbul Conference
- Leading pharma ingredients suppliers
- FREE Matchmaking Programme
- Top pharma machinery suppliers
- Latest Product Innovations
- Premier Contract Manufacturing providers
- Networking Opportunities
- Best Packaging solutions suppliers
Watch the CPhI Istanbul 2015 Highlights video: https://www.youtube.com/watch?v=dtRMe1X7ncg
Changes in the market environment, together with an aging population result in a great drug demand, especially in the generic and biotechnology sectors. Building partnerships and understanding the market are crucial success factors in this growing market - expected to be valued at US $166 billion by 2023.
Why visit CPhI Japan 2016?
1. Meet the Japanese pharma industry under one roof, with 460+ exhibiting companies from 27 countries;
2. Unrivalled, free of charge access to insight and information on the local market and its regulations via government workshops held at the event;
3. Conference running throughout the exhibition;
4. Pre-schedule meetings with exhibitors via the Buyer Appointment System;
5. A mobile app, available on all devices with an internet connection! Providing the exhibitor list, floor plan and schedule on the go.
Aenova Group has signed a definitive agreement to sell Swiss Caps USA’s softgel manufacturing facility in Miami, FL, to Marine Ingredients, a leading omega-3 manufacturer. As part of the agreement, the employees currently working in Miami will transfer from Swiss Caps USA to Innova Softgel, LLC, a newly formed subsidiary of Marine Ingredients. Both parties agreed not to disclose financial details of the transaction, which is expected to be closed by the end of December.
Sanofi and Boehringer Ingelheim today have entered into exclusive negotiations to swap businesses. The proposed transaction would consist of an exchange of Sanofi animal health business (Merial) with an enterprise value of €11.4 bn and Boehringer Ingelheim consumer healthcare (CHC) business with an enterprise value of €6.7 bn. Boehringer Ingelheim CHC business in China would be excluded from the transaction. The transaction would also include a gross cash payment from Boehringer Ingelheim to Sanofi of €4.7 bn.
Sanofi would become a global leader in consumer healthcare and Boehringer Ingelheim would become second largest animal health company.
Capsugel, Xcelience and Powdersize have announced that the three companies have entered into a definitive agreement under which Capsugel will acquire both Xcelience and Powdersize. The transaction, which is subject to regulatory approval, will further enhance Capsugel’s position as a leading provider of innovative dosage forms and solutions to healthcare customers around the world.
Upon completion of the transaction, both Xcelience and Powdersize will be integrated with Capsugel’s Dosage Form Solutions business unit, which has built a premier offering in bioavailability enhancement, a complete range of modified release solutions and a growing suite of applications in other areas, including bio-therapeutics, inhalation and pediatric formulations.
Analysis from Frost & Sullivan, 'Advanced Mechanisms in Drug Delivery', finds hydrogels, phospholipids, microspheres, cyclodextrins and nanotechnology based formulations are emerging drug delivery mechanisms that will displace established technologies such as polymeric micelles, niosomes, phosphorous acids and starch-based structures. Not only are these new-age drug delivery mechanisms biodegradable and non-toxic, they also enhance the bioavailability of drugs, promote solubility in various environments and ensure targeted delivery. Biodegradable and non-toxic drug delivery mechanisms will replace the current methods. These emerging drug delivery mechanisms will enhance the bioavailability of drugs, promote solubility in various environments and ensure targeted delivery.
If you recently launched an innovative health product, you have the exclusive opportunity to take part in the Pharmapack Europe Awards!
Enter the competition for Heath Products, the award honouring pharma companies who have seen their drug or medical device with an innovative packaging solution enter the European market between March 2015 and January 2016. Entries will be evaluated by a panel of independent doctors and pharmacists. After reviewing all entries, the jury members will decide amongst the three best innovations submitted.
Entries must be submitted by November 27th. Full details are available on the web site.
